Sep 14, 2022 / 07:30PM GMT
Unidentified Analyst -
Good afternoon. I'm going to read the disclosure, first of all. For important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Well, great. Well, welcome, Tim.
Timothy P. Clackson - Theseus Pharmaceuticals, Inc. - CEO, President & Director
Thank you.
Unidentified Analyst -
Clackson, CEO, Theseus Pharmaceuticals. Perhaps before diving into some granular questions, it would be great to just provide an overview on the company's focus with respect to cancer-resistant and pan-variant TKIs. And why this is important.
Timothy P. Clackson - Theseus Pharmaceuticals, Inc. - CEO, President & Director
Great. I'd be happy to. So first, thanks, Jessica, for the opportunity. And it's great to have a chance to describe what
Theseus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot